Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation

Cancer Letters

Volumn 314, Issue 1, 2012, Pages 102-107

  Li, Changyou ^a   Johnson, Daniel E ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Bcl 2; Bortezomib; HNSCC; JNK

Indexed keywords

AUTOPHAGY REGULATOR PROTEIN; BORTEZOMIB; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; REGULATOR PROTEIN; SERINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; BORONIC ACIDS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZINES;

EID: 82355175279     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.020     Document Type: Article

References (38)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59:225-249.
2. Mao L., Hong W.K., Papadimitrakopoulou V.A. Focus on head and neck cancer. Cancer Cell 2004, 5:311-316.
3. Gibson M.K., Forastiere A.A. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol. 2006, 7:565-574.
4. Khuri F.R., Shin D.M., Glisson B.S., Lippman S.M., Hong W.K. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin. Oncol. 2000, 27:25-33.
5. Forastiere A., Koch W., Trotti A., Sidransky D. Head and neck cancer. N Engl. J. Med. 2001, 345:1890-1900.
6. Mizushima N. Autophagy: process and function. Genes. Dev. 2007, 21:2861-2873.
7. Xie Z., Klionsky D.J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 2007, 9:1102-1109.
8. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
9. Kabeya Y., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
10. Sunwoo J.B., et al. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 2001, 7:1419-1428.
11. Fribley A., Zeng Q., Wang C.Y. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol. Cell. Biol. 2004, 24:9695-9704.
12. Li C., Li R., Grandis J.R., Johnson D.E. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells. Mol. Cancer Ther. 2008, 7:1647-1655.
13. Li C., Zang Y., Sen M., Leeman-Neill R.J., Man D.S., Grandis J.R., Johnson D.E. Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death. Mol. Cancer Ther. 2009, 8:2211-2220.
14. Ding W.X., Yin X.M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008, 4:141-150.
15. McConkey D.J., Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist. Updat. 2008, 11:164-179.
16. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
17. Koumenis C., Naczki C., Koritzinsky M., Rastani S., Diehl A., Sonenberg N., Koromilas A., Wouters B.G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002, 22:7405-7416.
18. Park M.A., Curiel D.T., Koumenis C., Graf M., Chen C.S., Fisher P.B., Grant S., Dent P. PERK-dependent regulation of HSP70 expression and the regulation of autophagy. Autophagy 2008, 4:364-367.
19. Rzymski T., et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010, 29:4424-4435.
20. Yang Y., Ikezoe T., Saito T., Kobayashi M., Koeffler H.P., Taguchi H. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling. Cancer Sci. 2004, 95:176-180.
21. Dai Y., Rahmani M., Pei X.Y., Dent P., Grant S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms. Blood 2004, 104:509-518.
22. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 2008, 30:678-688.
23. Pattingre S., Bauvy C., Carpentier S., Levade T., Levine B., Codogno P. Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J. Biol. Chem. 2009, 284:2719-2728.
24. Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007, 29:163-188.
25. Ding W.X., Ni H.M., Gao W., Yoshimori T., Stolz D.B., Ron D., Yin X.M. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 2007, 171:513-524.
26. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
27. Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005, 1:84-91.
28. Zhu K., Dunner K., McConkey D.J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010, 29:451-462.
29. Ding W.X., Ni H.M., Gao W., Chen X., Kang J.H., Stolz D.B., Liu J., Yin X.M. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Mol. Cancer Ther. 2009, 8:2036-2045.
30. Hoang B., Benavides A., Shi Y., Frost P., Lichtenstein A. Effect of autophagy on multiple myeloma cell viability. Mol. Cancer Ther. 2009, 8:1974-1984.
31. Belloni D., Veschini L., Foglieni C., Dell'Antonio G., Caligaris-Cappio F., Ferrarini M., Ferrero E. Bortezomib induces autophagic death in proliferating human endothelial cells. Exp. Cell Res. 2010, 316:1010-1018.
32. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
33. Maiuri M.C., et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007, 26:2527-2539.
34. Erlich S., et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy 2007, 3:561-568.
35. Trask D.K., Wolf G.T., Bradford C.R., Fisher S.G., Devaney K., Johnson M., Singleton T., Wicha M. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 2002, 112:638-644.
36. Li D.D., et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009, 28:886-898.
37. Park K.J., Lee S.H., Lee C.H., Jang J.Y., Chung J., Kwon M.H., Kim Y.S. Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem. Biophys. Res. Commun. 2009, 382:726-729.
38. Lorin S., Borges A., Ribeiro Dos Santos L., Souquere S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. C-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res. 2009, 69:6924-6931.